Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
BörsenkürzelZTS
Name des UnternehmensZoetis Inc
IPO-datumFeb 01, 2013
CEOPeck (Kristin C)
Anzahl der mitarbeiter13800
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 01
Addresse10 Sylvan Way
StadtPARSIPPANY
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl07054
Telefon19738227000
Websitehttps://www.zoetis.com/
BörsenkürzelZTS
IPO-datumFeb 01, 2013
CEOPeck (Kristin C)